Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.

BACKGROUND: Hydroxychloroquine (HCQ) is an anti-malarial and immunomodulatory drug considered a potential candidate for drug repurposing in COVID-19 due to their in vitro antiviral activity against SARS-CoV-2. Despite the potential antiviral effects and anti-inflammatory profile, the results based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-Filho, Paulo Ricardo, Ferreira, Lis Campos, Heimfarth, Luana, Araújo, Adriano Antunes de Souza, Quintans-Júnior, Lucindo José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403035/
https://www.ncbi.nlm.nih.gov/pubmed/34485970
http://dx.doi.org/10.1016/j.lana.2021.100062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403035/
https://www.ncbi.nlm.nih.gov/pubmed/34485970
http://dx.doi.org/10.1016/j.lana.2021.100062

Ejemplares similares